Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo

Hypertension

Volumn 46, Issue 1, 2005, Pages 87-92

  Fecteau, Marie Hélène ^a   Honoré, Jean Claude ^a   Plante, Mirco ^a   Labonté, Julie ^a   Rae, Giles A ^b   D'Orléans Juste, Pedro ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Arterial pressure; Endothelin; Plasma; Rabbits

Indexed keywords

CGS 35066; ENDOTHELIN 1; ENDOTHELIN 1 (1-31); ENDOTHELIN 1 (1-38); ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON; THIORPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HEART LEFT VENTRICLE; HEART RATE; HEMODYNAMICS; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RABBIT;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BENZOFURANS; BLOOD PRESSURE; ENDOTHELIN-1; FEMALE; GLYCOPEPTIDES; HEART VENTRICLES; INJECTIONS; MALE; METALLOENDOPEPTIDASES; NEPRILYSIN; PEPTIDE FRAGMENTS; PHOSPHONIC ACIDS; PROTEASE INHIBITORS; RABBITS; RECEPTORS, ENDOTHELIN; THIORPHAN;

EID: 21744460362     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000170460.24604.23     Document Type: Article

References (27)

1. D'Orleans-Juste P, Plante M, Honore JC, Carrier E, Labonte J. Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol. 2003;81:503-510.
2. Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol. 1997;159:1987-1992.
3. Nagata N, Niwa Y, Nakaya Y. A novel 31-amino-acid-length endothelin, ET-1(1-31), can act as a biologically active peptide for vascular smooth muscle cells. Biochem Biophys Res Commun. 2000;275:595-600.
4. Hayasaki-Kajiwara Y, Naya N, Shimamura T, Iwasaki T, Nakajima M. Endothelin generating pathway through endothelin-1(1-31) in human cultured bronchial smooth muscle cells. Br J Pharmacol. 1999;127:1415-1421.
5. Maguire JJ, Kuc RE, Davenport AP. Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro. Br J Pharmacol. 2001;134:1360-1366.
6. Leslie SJ, Rahman MQ, Denvir MA, Newby DE, Webb DJ. Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br J Clin Pharmacol. 2004;57:720-725.
7. Goldie RG, D'Aprile AC, Self GJ, Rigby PJ, Henry PJ. Influence of endothelin-1(1-31) on smooth muscle tone and cholinergic nerve-mediated contraction in rat isolated trachea. J Cardiovasc Pharmacol. 2000;36:S228-S231.
8. Yoshizumi M, Kim S, Kagami S, Hamaguchi A, Tsuchiya K, Houchi H, Iwao H, Kido H, Tamaki T. Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol. 1998;125:1019-1027.
9. Inui D, Yoshizumi M, Okishima N, Houchi H, Tsuchiya K, Kido H, Tamaki T. Mechanism of endothelin-1-(1-31)-induced calcium signaling in human coronary artery smooth muscle cells. Am J Physiol. 1999;276: E1067-E1072.
10. Okishima N, Yoshizumi M, Tsuchiya K, Cui P, Kitamura H, Tamaki T, Kido H. Determination of the levels of novel 31-amino acid endothelins and endothelins in human lungs. Life Sci. 2001;68:2073-2080.
11. Honore JC, Plante M, Bkaily G, Rae GA, D'Orleans-Juste P. Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs. Br J Pharmacol. 2002;136:819-828.
12. Mazzocchi G, Rossi GP, Malendowicz LK, Champion HC, Nussdorfer GG. Endothelin-1[1-31], acting as an ETA-receptor selective agonist, stimulates proliferation of cultured rat zona glomerulosa cells. FEBS Lett. 2000;487:194-198.
13. Rebuffat P, Malendowicz LK, Neri G, Nussdorfer GG. Endothelin-1[1-31] acts as a selective ETA-receptor agonist in the rat adrenal cortex. Histol Histopathol. 2001;16:535-540.
14. Niwa Y, Nagata N, Oka M, Toyoshima T, Akiyoshi H, Wada T, Nakaya Y. Production of nitric oxide from endothelial cells by 3,1-amino-acid-length endothelin-1, a novel vasoconstrictive product by human chymase. Life Sci. 2000;67:1103-1109.
15. Gratton JP, Rae GA, Bkaily G, D'Orleans-Juste P. ET(B) receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit. Hypertension. 2000;35:726-731.
16. Gratton JP, Cournoyer G, Loffler BM, Sirois P, D'Orleans-Juste P. ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension. 1997;30:1204-1209.
17. Fukuroda T, Noguchi K, Tsuchida S, Nishikibe M, Ikemoto F, Okada K, Yano M. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem Biophys Res Commun. 1990;172:390-395.
18. Roques BP, Fournie-Zaluski MC, Soroca E, Lecomte JM, Malfroy B, Llorens C, Schwartz JC. The enkephalinase inhibitor thiorphan shows aminociceptive activity in mice. Nature. 1980;288:286-288.
19. Jeng AY, De Lombaert S, Beil ME, Bruseo CW, Savage P, Chdu M, Trapani AJ. Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066. J Cardiovasc Pharmacol. 2000;36:S36-S39.
20. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe N, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A. 1994;91:4892-4896.
21. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50:247-255.
22. Okada K, Takada J, Arai Y, Matsuyama K, Yano M. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Biochem Biophys Res Commun. 1991;180:1019-1023.
23. Mawatari K, Kakui S, Harada N, Ohnishi T, Niwa Y, Okada K, Takahashi A, Izumi K, Nakaya Y. Endothelin-1(1-31) levels are increased in atherosclerotic lesions of the thoracic aorta of hypercholesterolemic hamsters. Atherosclerosis. 2004;175:203-212.
24. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 2003;107:2555-2558.
25. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900.
26. Doggrell SA, Wanstall JC. Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Cardiovasc Res. 2004;61:653-662.
27. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002;19:879-885.